Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1708 ARTÍCULOS , VIENDO DEL 1426 AL 1440

Mild cognitive impairment and dementia in older patients attending a general hospital in south India: DSM-5 standards and correlates

Varghese AP, Prasad J, Jacob KS.

Int Psychogeriatr. 2019 Jan;31(1):133-138. doi: 10.1017/S1041610218000625. Epub 2018 May 25.

The AD8 (Dementia Screening Interview) is a valid and reliable screening scale not only for dementia but also for mild cognitive impairment in the Turkish geriatric outpatients

Usarel C, Dokuzlar O, Aydin AE, Soysal P, Isik AT.

Int Psychogeriatr. 2019 Feb;31(2):223-229. doi: 10.1017/S1041610218000674. Epub 2018 Jun 20.

Models for predicting risk of dementia: a systematic review

Hou XH, Feng L, Zhang C, Cao XP, Tan L, Yu JT.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):373-379. doi: 10.1136/jnnp-2018-318212. Epub 2018 Jun 28.

APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis

Uddin MS, Kabir MT, Al Mamun A, Abdel-Daim MM, Barreto GE, Ashraf GM.

Mol Neurobiol. 2019 Apr;56(4):2450-2465. doi: 10.1007/s12035-018-1237-z. Epub 2018 Jul 21.

Validation study of a Spanish version of the modified Telephone Interview for Cognitive Status (STICS-m)

Muñoz-García M, Cervantes S, Razquin C, Guillén-Grima F, Toledo JB, Martínez-González MÁ, Toledo E.

Gac Sanit. 2019 Sep-Oct;33(5):415-420. doi: 10.1016/j.gaceta.2018.05.004. Epub 2018 Jul 24.

DAPK1: a Novel Pathology and Treatment Target for Alzheimer's Disease

Xu LZ, Li BQ, Jia JP.

Mol Neurobiol. 2019 Apr;56(4):2838-2844. doi: 10.1007/s12035-018-1242-2. Epub 2018 Jul 31.

Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study

Andre L, Gallini A, Montastruc F, Coley N, Montastruc JL, Vellas B, Andrieu S, Gardette V; MAPT/DSA study group.

Br J Clin Pharmacol. 2019 Jan;85(1):71-99. doi: 10.1111/bcp.13734. Epub 2018 Oct 17.

Energy and Protein Intake of Alzheimer's Disease Patients Compared to Cognitively Normal Controls: Systematic Review

Doorduijn AS, van de Rest O, van der Flier WM, Visser M, de van der Schueren MAE.

J Am Med Dir Assoc. 2019 Jan;20(1):14-21. doi: 10.1016/j.jamda.2018.06.019. Epub 2018 Aug 9.

Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer's Disease?

Merlo S, Spampinato SF, Sortino MA.

CNS Neurosci Ther. 2019 Jan;25(1):5-13. doi: 10.1111/cns.13050. Epub 2018 Aug 12.

Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline

Chornenkyy Y, Wang WX, Wei A, Nelson PT.

Brain Pathol. 2019 Jan;29(1):3-17. doi: 10.1111/bpa.12655. Epub 2018 Oct 9.

Definition of Late Onset Alzheimer's Disease and Anticipation Effect of Genome-Wide Significant Risk Variants: Pilot Study of the APOE e4 Allele

De Luca V, Spalletta G, Souza RP, Graff A, Bastos-Rodrigues L, Camargos Bicalho MA.

Neuropsychobiology. 2019;77(1):8-12. doi: 10.1159/000490739. Epub 2018 Aug 15.

Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis

Chan VTT, Sun Z, Tang S, Chen LJ, Wong A, Tham CC, Wong TY, Chen C, Ikram MK, Whitson HE, Lad EM, Mok VCT, Cheung CY.

Ophthalmology. 2019 Apr;126(4):497-510. doi: 10.1016/j.ophtha.2018.08.009. Epub 2018 Aug 13.

Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment

Chandra A, Dervenoulas G, Politis M; Alzheimer’s Disease Neuroimaging Initiative.

J Neurol. 2019 Jun;266(6):1293-1302. doi: 10.1007/s00415-018-9016-3. Epub 2018 Aug 17.

Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors

Takeda S.

Neurosci Res. 2019 Apr;141:36-42. doi: 10.1016/j.neures.2018.08.005. Epub 2018 Aug 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias